coronavirus InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients – Yahoo Finance Posted on April 4, 2023 by admin InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients Yahoo Finance admin Did Covid Break Europe’s Healthcare Systems? – Bloomberg The CDC keeps pushing COVID boosters on kids despite real health risks – New York Post